Healthcare worker holding Dabrafenib cancer drug packaging. This medication, marketed as Tafinlar, is a cancer growth blocker drug used to treat melanoma skin cancer and advanced non small cell lung cancer. Dabrafenib is used in patients that have a mutation in the BRAF gene. Dabrafenib blocks the abnormal protein produced that signals for cancer cells to multiply.